![Michael Egholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Egholm
Vorstandsvorsitzender bei
STANDARD BIOTOOLS INC.
Vermögen: 5 Mio $ am 30.06.2026
Profil
Michael Egholm was the founder of Danaher Corp., founded in 2017, where the title held was Chief Technology Officer-Danaher Life Sciences from 2017 to 2021.
Current jobs include President, Chief Executive Officer & Director at Standard BioTools, Inc. since 2021; Director at Abbratech, Inc.; and Member at the Royal Danish Academy of Sciences & Letters.
Former jobs include President, CEO, Secretary, Treasurer & Director at SomaLogic, Inc.; Independent Director at IsoPlexis Corp.
from 2018 to 2022; President-Biopharmaceuticals at Pall Corp.
from 2014 to 2017; Vice President-Research at Molecular Staging, Inc.; Chief Technology Officer at Roche Applied Science from 2008 to 2010; and Chief Technology Officer at 454 Life Sciences Corp.
from 2004 to 2010.
Education includes a doctorate from the University of Copenhagen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.08.2026 | 6 235 331 ( 1,6 % ) | 5 Mio $ | 30.06.2026 |
Aktive Positionen von Michael Egholm
| Unternehmen | Position | Beginn |
|---|---|---|
| STANDARD BIOTOOLS INC. | Vorstandsvorsitzender | 01.10.2021 |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Direktor/Vorstandsmitglied | - |
Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Egholm
| Unternehmen | Position | Ende |
|---|---|---|
| ISOPLEXIS CORPORATION | Direktor/Vorstandsmitglied | 22.08.2022 |
| DANAHER CORPORATION | Gründer | 01.09.2021 |
| PALL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 10.09.2014 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2010 |
Roche Applied Science
 Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Ausbildung von Michael Egholm
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Danaher Corp.
 Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Molecular Staging, Inc.
 Molecular Staging, Inc. Medical SpecialtiesHealth Technology Develops products for the detection & measurement of proteins and nucleic acids | Health Technology |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Applied Science
Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Commercial Services |
Royal Danish Academy of Sciences & Letters | |
SomaLogic, Inc.
 SomaLogic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a protein biomarker discovery and clinical diagnostics company | Commercial Services |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
